Background: Melasma is a skin disorder characterized by light-to-deep brown pigmentation on the cheeks, forehead, upper lip, and nose. Its prevalence rate is high and its treatment is challenging. Objective: The aim of this study was to compare the efficacy of glycolic acid 60% peel versus Q-switched Nd:YAG laser in the treatment of melisma Materials and method: This quasi-experimental study was carried out at the Dermatology department, Northwest General Hospital Peshawar from January 2026 to June 2026. The sample size was calculated using the WHO sample size calculator. A total of 50 patients of both genders (aged 20–62 years) who had melasma with baseline MASI scores of 6–20 were included. Demographic and clinical data, including sex, age, skin type, lesion examination and MASI score, were recorded. The patients were allocated to group A and group B by using lottery method. In group A, patients were treated with 60% glycolic acid peel. Patients in group B were treated with a Q-switched Nd:YAG laser of a 1064 nm wavelength. The outcome was evaluated at two, four, six, eight, ten, and twelve weeks. SPSS version 16 was applied for data analysis. Results: A total of 50 patients were enrolled and divided into group A (glycolic acid) and group B (laser). In A group female were 15(60%) and male were 10(40%) while in group B female were 20(80%) and male were 5(20%). The mean age of the study participants in laser group was 33.71±5.86 and glycolic acid group was 34.16 ±5.92 years. The most aggravating factor was sunlight 15(30%) followed by cosmetics in 11(22%) and OCPs 7(14%). MASI scores of the two groups were compared at baseline and after 12 weeks of follow-up. Baseline MASI was higher in group A than in group B (median 7.22 vs 5.42, p < 0.001). The groups differed significantly up to week 8 (p < 0.05) but not at weeks 10 and 12 (p > 0.05), when the median MASI was 3.00 in both groups. The commonest response in group A was 20–50% improvement (15 patients, 60%), whereas in group B it was below 20% (13 patients, 52%). Conclusion: Glycolic acid 60% peel and Q-switched Nd:YAG laser produced comparable improvement in MASI over 12 weeks, with no significant difference between them. Erythema was more frequent with glycolic acid, whereas post-inflammatory hyperpigmentation was seen more often with laser.
Melasma is a chronic skin disorder that is characterized by a brown to grayish-brown hyperpigmented spots on the face. Its exact mechanism of pathogenesis is unclear. Various factors including pregnancy, genetic predisposition, UV light exposure, hormone effects, the use of oral contraception, and hormone replacement treatment aggravate melasma [1, 2]. Furthermore, the significance of UV radiation in the activation of melanocytes is widely recognized, making sun exposure a key exacerbating factor [3]. Melasma therapy techniques now focus on depigmentation, melanogenesis suppression, and epidermal turnover stimulation. Although topical medications such as hydroquinone, retinoic acid, and azelaic acid are often utilized, their long-term effectiveness is limited, and recurrences are frequently seen after therapy [4]. As a result, procedural treatments including chemical peels and laser therapy have gained popularity as supplementary or alternative treatments [5].
Chemical peels, such as glycolic acid, salicylic acid, and trichloroacetic acid (TCA), increase stratum corneum exfoliation, which speeds up epidermal turnover and reduces melanin content in the skin's surface layers. Chemical peels have a progressive efficacy, needing numerous sessions for obvious improvement, and the depth of the peel determines both effectiveness and risk profile [6,7]. Deeper peels provide more noticeable effects, but they also have a greater likelihood of problems including scarring or extended erythema [8].
Laser treatments, on the other hand, offer more specific therapy. Q-switched Nd lasers and fractional lasers are two of the most often utilized technologies for melasma. They target melanin at various skin depths by selective photothermolysis [9]. Lasers can target both epidermal and dermal melasma. However, lasers can cause post-inflammatory hyperpigmentation (PIH), especially in individuals with darker skin types (Fitzpatrick III-VI). PIH is caused by excessive stimulation of melanocytes during the healing process, which leads to additional darkening of the treated region [10]. Sun protection, azelaic acid, hydroquinone, and kojic acid are all beneficial in the treatment of melasma, however the Kligman formula remains the conventional first-line therapy. Glycolic acid (20% - 70%) is an efficient and safe chemical peel because of its exfoliant characteristics and capacity to induce cell turnover. At the same time, the non-invasive Q-switched Nd:YAG laser destroys the melanin granules of epidermal or dermal melasma, which are subsequently phagocytosed by macrophages[11]. The aim of this study was to compare the efficacy of glycolic acid 60% peel versus Q-switched Nd:YAG laser in the treatment of melasma.
This quasi-experimental study was carried out at the Dermatology department, Northwest General Hospital Peshawar from January 2026 to June 2026. The sample size was calculated using the WHO sample size calculator. A total of 50 patients of both genders (aged 20–62 years) who had melasma with baseline MASI scores of 6–20 was included. Individuals with known hypersensitivity to the chemical peel, endocrinological disorder, on hormone therapy, lactating and pregnant women and those with viral or bacterial infections were excluded from the study.
Demographic and clinical data, including sex, age, skin type, lesion examination and MASI score, were recorded. The patients were allocated equally to group A (n = 25) and group B (n = 25) by using lottery method. In group A, patients were treated with 60% glycolic acid applied for 2 minutes, starting from the forehead and then the nose and chin, every two weeks for 12 weeks The peel was terminated by washing with cold water. Participants in B group were treated with a Q-switched Nd:YAG laser of a 1064 nm wavelength, produced by BVLASER Company. The treatment area was washed, and a Q-switched Nd:YAG laser was delivered with a 3mm spot size, an energy fluence of, and a repetition frequency of 6 Hz.
Two to three passes were made over the lesions, moving the handpiece slowly. The participants were then told to wear sunscreen during the day. The outcome (MASI score) was evaluated at two, four, six, eight, ten, and twelve weeks. SPSS version 16 was applied for data analysis. Quantitative variables (age, baseline and post-treatment MASI score) were expressed as mean ± SD or median (IQR). The Mann-Whitney U test was used to compare MASI scores between the groups at each time point. Categorical variables were expressed as frequencies and percentages and compared using the chi-square test or Fisher exact test (when expected counts were below 5). P value less than 0.05 was considered statistically significant.
A total of 50 patients were enrolled and divided into group A (glycolic acid) and group B (laser). In A group female were 15(60%) and male were 10(40%) while in group B female were 20(80%) and male were 5(20%). The mean age of the study participants in laser group was 33.71±5.86 and glycolic acid group was 34.16 ±5.92 years. The most prevalent pattern was centrofacial, followed by malar.
Epidermal melasma was seen in 24 (48%) patients, dermal in 2 (4%) and mixed in 24 (48%), as assessed clinically and by Wood's lamp. Melasma ranged from 1-15 years. Melasma for less than 3 years in both groups was noted in 23(46%), 11 (22%) for 3-5 years and 16 (32%) had melasma for more than 5 years duration. Sun exposure for more than 2 hours was observed in 15(30%), and less than 2 hours was recorded in 35(70%) individuals as presented in table 1.
The most aggravating factor was sunlight 15(30%) followed by cosmetics in 11(22%) and OCPs 7(14%) as presented in table 2. MASI scores of the two groups were compared at baseline and after 12 weeks of follow-up. The findings were expressed as the median and interquartile range (IQR). To compare the two groups at each assessment point Mann-Whitney U test was employed. Baseline MASI was higher in group A than in group B (median 7.22 vs 5.42, p < 0.001).
The groups differed significantly up to week 8 (p < 0.05) but not at weeks 10 and 12 (p > 0.05), when the median MASI was 3.00 in both groups (Table 3).
The commonest response in group A was 20–50% improvement (15 patients, 60%), whereas in group B it was below 20% (13 patients, 52%). Improvement above 50% was seen in 3 (12%) patients in group A and 1 (4%) in group B; the difference between the groups was not significant (p = 0.20) (Table 4).
The commonest adverse effect was erythema, seen in 12 patients in group A and 8 in group B, followed by hyperpigmentation in 4 patients in group A and 9 in group B (Table 5).
Table 1. Demographic features of the study population N= 50
|
Features |
Group A |
Group B |
P value |
|
Gender |
|||
|
Female |
15(60%) |
20(80%) |
0.22 |
|
Male |
10(40%) |
5(20%) |
|
|
Mean age in years |
34.16 ±5.92 |
33.71±5.86 |
- |
|
Melasma duration |
|||
|
Less than 3 years |
10(40%) |
13(52%) |
0.29 |
|
3 to five years |
8(32%) |
3(12%) |
|
|
Above 5 years |
7(28%) |
9(36%) |
|
|
Melasma types |
|||
|
Dermal |
0(0%) |
2(8%) |
0.57 |
|
Epidermal |
13(52%) |
11(44%) |
|
|
Mix |
12(48%) |
12(48%) |
|
|
Sunlight exposure |
|||
|
Less than 2 hours |
15(60%) |
20(80%) |
0.22 |
|
More than 2 hours |
10(40%) |
5(20%) |
|
Table 2. Aggravating factors in the two groups (n = 50)
|
Aggravating factors |
Group A |
Group B |
Total |
P value |
|
OCPs |
4(16%) |
3(12%) |
7(14%) |
1.00 |
|
Others |
0(0%) |
0(0%) |
0(0%) |
- |
|
Cosmetics |
3(12%) |
8(32%) |
11(22%) |
0.17 |
|
Sunlight |
9(36%) |
6(24%) |
15(30%) |
0.54 |
Table 3. Comparison of MASI scores between the groups, median (IQR), Mann–Whitney U test
|
MASI scores |
Glycolic acid group |
Laser treated group |
P value |
|
0 base |
7.22(4.21) |
5.42(3.76) |
<0.001 |
|
2 weeks |
7.22(4.06) |
5.42(2.41) |
<0.001 |
|
4 weeks |
5.54(2.79) |
4.49(4.9) |
<0.001 |
|
6 weeks |
4.81(2.36) |
4.46(4.21) |
0.003 |
|
8 weeks |
4.21(2.66) |
4.11(2.28) |
0.005 |
|
10 weeks |
3.61(2.36) |
3.61(3.41) |
1.00 |
|
12 weeks |
3.00(2.31) |
3.00(3.31) |
1.00 |
Table 4. The responses in the two groups after 12 weeks.
|
Improvement |
Group A |
Group B |
Total |
|
Above 50% |
3(12%) |
1(4%) |
4(8%) |
|
20-50% |
15(60%) |
11(44%) |
26(52%) |
|
Below 20% |
7(28%) |
13(52%) |
20(40%) |
|
The difference between the groups was not significant (p = 0.20, Fisher–Freeman–Halton exact test). |
|||
Table 5. Adverse effects after therapy in both groups
|
Effects |
Group A |
Group B |
|
Frosting |
1 |
|
|
Transient burning |
- |
2 |
|
Mild scaling |
1 |
- |
|
Severe pigmentation |
- |
2 |
|
Moderate pigmentation |
- |
4 |
|
Mild pigmentation |
- |
2 |
|
Post-inflammatory hyperpigmentation |
4 |
9 |
|
Erythema |
12 |
8 |
Melasma is a common acquired pigmentary disorder characterized by symmetrically distributed medium to dark brown macules on sun-exposed parts of the face. It primarily affects those with darker skin types [12]. It is a major source of mental and psycho-social stress for both men and women in the modern society, which lowers their quality of life [13]. Sun protection is essential for managing melasma. Long-term usage of agents including kojic acid, azelaic acid, hydroquinone, tretinoin and rucinol, can provide benefits. The Kligman formula, a triple mixture of hydroquinone, tretinoin, and a moderate topical corticosteroid, is a conventional first-line therapy, however it comes with certain adverse effects [14]. Chemical peels and laser treatment may help control melasma. Glycolic acid, an alpha hydroxy acid, is usually employed as a chemical peel at concentrations ranging from 20% - 70%. They are effective and safe for those with skin types five and six, although the concentration and peeling time should be titrated with caution in these darker skin types [15].
Melasma can be treated with several lasers, including Q-switched Nd:YAG laser, which is widely used. Lasers damage the upper dermis' melanin granules, which are then absorbed by macrophages [16]. The present study was carried out to compare the efficacy of glycolic acid 60% peel versus Q-switched Nd:YAG laser in the treatment of melasma. A total of 50 patients were enrolled and divided into group A (glycolic acid) and group B (laser). In A group female were 15(60%) and male were 10(40%) while in group B female were 20(80%) and male were 5(20%). The mean age of the study participants in laser group was 33.71±5.86 and glycolic acid group was 34.16 ±5.92 years. Our study demographic features are similar to the study conducted by Rafique et al., in which females predominated and the mean age was 33.15 ± 4.90 years in the laser group and 32.70 ± 4.75 years in the glycolic acid group [17]. Our study findings are also comparable to the study carried out by Divya et al [18]. In their study females were 86.7% and males 13.3%. These results support our study. In our study the most prevalent pattern was centrofacial. This is comparable to the study by Wolfgang, in which the centrofacial pattern was most common [19], and to another previous study [17]. In our study epidermal melasma was seen in 48% of patients, dermal in 4% and mixed in 48%. These results are comparable to the studies of Rafique et al. [17] and Bosseila et al. [20].
In our study the most aggravating factor for melasma was sunlight. Similar findings were reported from the previous study [18]. Melasma is exacerbated by sunlight as visible and ultraviolet (UV) light stimulate melanocytes, which are pigment-producing cells that are extremely sensitive in melasma sufferers and produce extra melanin, the pigment that darkens skin, when exposed to heat, sun, or interior light. Baseline MASI was higher in group A than in group B (median 7.22 vs 5.42, p < 0.001). The groups differed significantly up to week 8 (p < 0.05) but not at weeks 10 and 12 (p > 0.05), when the median MASI was 3.00 in both groups. The difference at week 0 reflects unequal baseline MASI between the groups. Our study findings are similar to the previous studies [17],[18]. In our study, the commonest response was 20–50% improvement in group A (15 patients, 60%) and below 20% in group B (13 patients, 52%). Improvement above 50% was seen in 3 (12%) patients in group A and 1 (4%) in group B. These results are comparable with studies of Khan et al. [21] and Sachdeva et al. [22], who observed a 18% – 55% improvement in MASI scores following a 70% glycolic peel in 12 weeks. Glycolic acid compromises the skin's barrier function by weakening the stratum corneum's (SC) intercellular substance, which causes the SC's outermost layers to exfoliate uniformly. Additionally, glycolic acid has a "targeted" desmosomal activity without affecting the components that make up the skin's barrier [23]. Our findings were also consistent with those of Ertam et al. [24],
who demonstrated that a 1064 nm Q-switched Nd:YAG laser with low pulse energy (2.5 J/cm2, 6 mm) used twice a week for 12 weeks was a non-significant yet successful therapy for melasma when compared to chemical peel. The Q-switched Nd:YAG, a pigment-specific laser, performs a vital part in pigmentary illnesses by radiating energy at 1064 nm, which splits dermal and epidermal melanosomes in melanocytes via selective photothermolysis (less than 5 J/cm²). Important functions of lasers are destruction of dermal melanophage and breaking of granules of melanin without cellular damage. Kar et al. [25] reported similar outcomes, with an average improvement of 47.93% after treating twenty-five patients with laser treatment for 12 weeks. In this study the commonest adverse effect was erythema, seen in 12 patients in group A and 8 in group B, followed by hyperpigmentation in 4 patients in group A and 9 in group B. The higher frequency of hyperpigmentation after laser is comparable to that reported by Puri et al., who found hyperpigmentation to be the main side effect of laser treatment [26]. This study has limitations. It was a single-centre quasi-experimental study with a small sample and non-random allocation, and baseline MASI was higher in the glycolic acid group. Follow-up was limited to 12 weeks, so recurrence could not be assessed, and no patient-satisfaction or quality-of-life measure was used. Larger randomised studies with longer follow-up are needed.
Glycolic acid 60% peel and Q-switched Nd:YAG laser produced comparable improvement in MASI over 12 weeks, with no significant difference between them. Erythema was more frequent with glycolic acid, whereas post-inflammatory hyperpigmentation was seen more often with laser.